Literature DB >> 17028478

Managing hypertension: state of the science.

Jerome D Cohen1.   

Abstract

Hypertension management is both routine and a challenge. Updated guidelines emphasize the need to achieve increasingly stringent blood pressure goals to reduce cardiovascular morbidity and mortality; however, the blood pressure of many patients who have been diagnosed with hypertension is not well controlled. Treating prehypertension nonpharmacologically may preempt the progression to hypertension, whereas early and aggressive management of hypertension with antihypertensive agents reduces short- and long-term cardiovascular risk. Treatment decisions should follow current guidelines while evaluating recently published clinical studies. When choosing between agents from different therapeutic classes or combining agents, physicians should consider current and targeted blood pressure levels, the patient's demographic profile, the presence or absence of compelling cardiovascular and metabolic indications, other comorbidities, and concurrent medication(s).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028478      PMCID: PMC8109734          DOI: 10.1111/j.1524-6175.2006.05923.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  21 in total

1.  Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation.

Authors:  W F Keane; G Eknoyan
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

2.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

3.  Hypertension management in adults with diabetes.

Authors:  Carlos Arauz-Pacheco; Marian A Parrott; Phillip Raskin
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

4.  Racial/ethnic disparities in prevalence, treatment, and control of hypertension--United States, 1999-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-01-14       Impact factor: 17.586

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors:  F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

Review 7.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Authors:  G L Bakris; M Williams; L Dworkin; W J Elliott; M Epstein; R Toto; K Tuttle; J Douglas; W Hsueh; J Sowers
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

8.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Authors:  Carl J Pepine; Eileen M Handberg; Rhonda M Cooper-DeHoff; Ronald G Marks; Peter Kowey; Franz H Messerli; Giuseppe Mancia; José L Cangiano; David Garcia-Barreto; Matyas Keltai; Serap Erdine; Heather A Bristol; H Robert Kolb; George L Bakris; Jerome D Cohen; William W Parmley
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

9.  Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group.

Authors:  J D Neaton; D N Wentworth; J Cutler; J Stamler; L Kuller
Journal:  Ann Epidemiol       Date:  1993-09       Impact factor: 3.797

10.  Deaths: leading causes for 2001.

Authors:  Robert N Anderson; Betty L Smith
Journal:  Natl Vital Stat Rep       Date:  2003-11-07
View more
  2 in total

Review 1.  Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.

Authors:  Timothy L Reudelhuber; Kenneth E Bernstein; Patrick Delafontaine
Journal:  Hypertension       Date:  2007-04-23       Impact factor: 10.190

2.  Characteristics of patients prescribed angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or the combination at an urban medical center.

Authors:  Ghania Masri; Kristi Bledsoe; Carlos Palacio
Journal:  MedGenMed       Date:  2007-11-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.